A drug with the SMILES CSc1nnc(C2CCN(CC(=O)Nc3ccccc3N3CCOCC3)CC2)n1C(C)C has a human ether-à-go-go related gene (hERG) inhibition at 1uM of 6.420\%.
A {#drug|compound!} with the {SMILES__description} {SMILES#} has a {herg_central_at_1uM__names__noun} of {herg_central_at_1uM#}{herg_central_at_1uM__units}.
CSc1nnc(C2CCN(CC(=O)Nc3ccccc3N3CCOCC3)CC2)n1C(C)C
CSc1nnc(C2CCN(CC(=O)Nc3ccccc3N3CCOCC3)CC2)n1C(C)C
2-[4-(5-methylsulfanyl-4-propan-2-yl-1,2,4-triazol-3-yl)piperidin-1-yl]-N-(2-morpholin-4-ylphenyl)acetamide